STAT1 and COVID-19: The ability of plasma anti-IFNα autoantibodies to block signal transducer and activator of transcription 1 (STAT1) phosphorylation by recombinant human IFNα in vitro was assessed by flow cytometry.<h4>Results</h4>Ten SLE subjects with COVID-19 were identified.